Package Insert: Information for the Patient
Domex 10 mg/10 mg Film-Coated Tablets
Donepezil Hydrochloride/Memantine Hydrochloride
Read this entire package insert carefully before starting to take this medication, as it contains important information for you.
Contents of the package and additional information
How Domex is used
Domex is indicated as a substitute treatment in adult patients with moderate to severe Alzheimer's disease adequately controlled with a daily dose of 10 mg of donepezil and 10 mg of memantine, taken as a free combination.
How Domex works
Domex is a combination of an acetylcholinesterase inhibitor (donepezil) and an NMDA receptor antagonist (memantine). Acetylcholinesterase inhibitors, such as donepezil, increase brain levels of a substance related to memory (acetylcholine) by reducing the rate of decomposition of this substance. Memantine hydrochloride, by inhibiting NMDA receptor activity, improves nerve signal transmission and memory.
There is no evidence that Domex prevents or slows the underlying disease process in patients with Alzheimer's disease.
Warnings and precautions
Consult your doctor before starting to take Domex if you have or have had:
low levels of magnesium or potassium in the blood.
In the above situations, treatment should be closely monitored, and your doctor should regularly reevaluate the clinical benefit of Domex.
If you have kidney problems, your doctor should closely monitor your renal function and, if necessary, adjust the memantine dose.
If you have renal tubular acidosis (ATR, excessive acid-producing substances in the blood due to renal dysfunction) or severe urinary tract infections, your doctor may need to adjust the medication dose.
Inform your doctor if you have any liver disease. Domex can be used in patients with mild to moderate liver insufficiency. Patients with severe liver insufficiency should not take Domex.
You should avoid taking Domex with other acetylcholinesterase inhibitors and other cholinergic agonists or antagonists, with medications such as amantadine (for Parkinson's disease treatment), ketamine (a medication generally used for anesthesia), dextromethorphan (a medication for cough treatment), and other NMDA antagonists.
Children and adolescents
Domex is not recommended for use in children and adolescents under 18 years old.
Other medications and Domex
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication, especially, it is essential to inform your doctorif you are taking any of the following types ofmedications:
In the event of surgical intervention with general anesthesia, you should inform your doctor that you are taking Domex, as this may affect the amount of anesthetic needed.
If you are admitted to a hospital, inform your doctor that you are taking Domex.
Domex with food, drinks, and alcohol
You should inform your doctor if you have recently changed or intend to change your diet significantly (e.g., from a normal diet to a strict vegetarian diet).
This medication should not be taken with alcohol, as alcohol may modify the effect of this medication.
Pregnancy,breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
Do not take Domex if you are pregnant or think you may be pregnant.
Breastfeeding
Women taking Domex should not breastfeed.
Driving and operating machinery
Your doctor will inform you if your condition allows you to drive and use machinery safely.
Domex may also alter your reaction time, making driving or operating machinery inappropriate.
Dosage
The recommended dose in adult and elderly patients is 1 tablet administered once a day.
Dosage for patients with renal insufficiency
If you have kidney problems, your doctor will decide on the appropriate dose for your condition. In this case, your doctor must monitor your renal function periodically.
Dosage for patients with hepatic insufficiency
If you have mild or moderate liver disease, you can take this medication. Patients with severe liver disease should not take this medication.
Use in children and adolescents
This medication is not recommended for use in children and adolescents under 18 years old.
Form of use and route of administration
It is administered orally, with a little water, at night immediately before going to bed. The tablets can be taken with or without food.
If you have abnormal dreams, nightmares, or difficulty sleeping (see section 4), your doctor may recommend taking Domex in the morning.
The groove should not be used to split the tablet.
Treatment duration
Continue taking this medication as long as it is beneficial for you. Your doctor should evaluate the effects of your treatment periodically.
If you take moreDomexthan you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
The symptoms of overdose may include nausea, vomiting, drooling, sweating, decreased heart rate, low blood pressure (dizziness or dizziness when standing up), breathing problems, loss of consciousness, and seizures. You may experience an increase in the symptoms described in section 4 “Possible adverse effects”.
If you forgot to take Domex
If you realize you have forgotten to take your dose, wait and take the next dose at the usual time.
Do not take a double dose to compensate for the missed doses.
If you interrupt treatment withDomex
Do not stop taking this medication unless your doctor tells you to. If you stop taking this medication, the benefits of treatment will gradually disappear.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
The followingserious side effectshave been reported only with the use of donepezil as a single component. Inform your doctor immediately if you notice any of the following serious side effects, as you may need urgent medical treatment:
The side effects listed below reflect the frequencies previously reported for the individual components, donepezil (5-10 mg) or memantine (10-20 mg):
Donepezil
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Infrequent (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Frequency not known (the frequency cannot be estimated from the available data):
Memantine
Generally, the side effects are mild to moderate.
Common (may affect up to 1 in 10 people)
Infrequent (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 10,000 people)
Frequency not known (the frequency cannot be estimated from the available data)
Alzheimer's disease has been associated with depression, suicidal ideation, and suicide. There have been reports of these events in patients treated with memantine.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the national notification system: Spanish System of Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require special conservation conditions.
Medications should not be disposed of through drains or trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Domex
Appearance of the product and contents of the packaging
Domex 10 mg/10 mg is presented in the form of film-coated tablets, oblong, biconvex, white in color, with a notch on one of the faces. The notch should not be used to split the tablet.
The tablets are available in packaging with PVC/PCTFE/PVC-Aluminum blisters containing 28 tablets.
Holder of the marketing authorization and responsible for manufacturing
Laboratorios Alter, S.A.
C/ Mateo Inurria, 30
28036, Madrid
Spain
or
Laboratorios Alter, S.A.
C/ Zeus, 6
Polígono Industrial R2
28880, Meco (Madrid)
Spain
Last review date of this leaflet: October 2022
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/).
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.